AN1 0.00% 0.8¢ anagenics limited

Ann: Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,410 Posts.
    lightbulb Created with Sketch. 987
    "The FGF5 inhibitor aptamers add to the Company’s proprietary antiaging hair care technologies and underpin Cellmid’s scientific leadership in the field". (My emphasis)

    Yeah well, far be it for me to be negative...but I've seen this type of exciting statement before (specifically...midkine) and in the end that got all too hard for them to materialise into something monetarily tangible.

    As per Bariscan, I wonder if this ends up the same - or whether they can actually convert this into a money spinner "for the poor suffering shareholders"!

    Only time will tell.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.